Constellation Pharmaceuticals, Inc. appointed Emma Reeve as chief financial officer and Brad Prosek as senior vice president, corporate development. Prior to joining Constellation Pharmaceuticals, Emma served as interim chief financial officer and corporate controller of PAREXEL International, where she was responsible for all aspects of financial reporting and accounting, investor relations, financial planning and analysis. Previously, Brad Prosek spent 10 years at Cubist Pharmaceuticals, where he built the company's Market Access strategy
and organization, led transaction teams responsible for deals, including the acquisition of Trius Therapeutics, supporting the company's pipeline growth and led a new corporate venture building a complementary infection prevention business.